GYPA Human

Glycophorin A Human Recombinant
Shipped with Ice Packs
In Stock

Description

GYPA Human Recombinant produced in Sf9 Insect cells is a single, glycosylated polypeptide chain containing 81 amino acids (20-91a.a.) and having a molecular mass of 9.1kDa. (Molecular size on SDS-PAGE under reducing conditions 18-28kDa).
GYPA is expressed with a 9 amino acids His tag at C-Terminus and purified by proprietary chromatographic techniques.

Product Specs

Introduction
Glycophorins A and B (GYPA & GYPB) are the primary sialoglycoproteins found on the human erythrocyte membrane. They carry the antigenic determinants responsible for the MN and Ss blood groups. In addition to the M or N and S or s antigens commonly found in all populations, there are approximately 40 related variant phenotypes. These variants encompass all variations of the Miltenberger complex, certain isoforms of Sta, as well as Dantu, Sat, He, Mg, and deletion variants Ena, S-s-U-, and Mk. GYPA plays a crucial role in the function of SLC4A1, a protein essential for high activity of SLC4A1. GYPA facilitates the translocation of SLC4A1 to the plasma membrane. Furthermore, GYPA serves as a receptor for the influenza virus and Plasmodium falciparum erythrocyte-binding antigen 175 (EBA-175). The binding of EBA-175 relies on sialic acid residues present in the O-linked glycans. GYPA also acts as a receptor for the Hepatitis A virus (HAV).
Description
Recombinant human GYPA, produced in Sf9 insect cells, is a single, glycosylated polypeptide chain consisting of 81 amino acids (20-91a.a.). It has a molecular mass of 9.1 kDa. On SDS-PAGE under reducing conditions, its molecular size appears between 18-28 kDa. The protein is expressed with a 9 amino acid His tag at the C-terminus and purified using proprietary chromatographic methods.
Physical Appearance
A clear, colorless solution that has been sterilized by filtration.
Formulation
GYPA protein solution at a concentration of 1 mg/ml in Phosphate Buffered Saline (pH 7.4) with 10% glycerol.
Stability
For optimal storage, keep at 4°C if the entire vial will be used within 2-4 weeks. For longer-term storage, freeze at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for extended storage. Avoid repeated freeze-thaw cycles.
Purity
Purity exceeds 85.0% as determined by SDS-PAGE analysis.
Synonyms

Glycophorin A (MNS Blood Group), Glycophorin A (MN Blood Group), Sialoglycoprotein Alpha, MN Sialoglycoprotein, PAS-2, GPA, Erythroid-Lineage-Specific Membrane Sialoglycoprotein, Recombinant Glycophorin A-B Miltenberger-DR, Glycophorin A (Includes MN Blood Group),  Mi.V Glycoprotein (24 AA), Glycophorin Sta Type C, Glycophorin A, GPA, Glycophorin Erik, Glycophorin MiV, Glycophorin SAT, CD235a Antigen, Glycophorin-A, HGpSta(C),  HGpMiXI, CD235a, GPErik, HGpMiV, GPSAT, MNS, MN.

Source
Sf9, Insect cells.
Amino Acid Sequence

ADPLSTTEVA MHTSTSSSVT KSYISSQTND THKRDTYAAT PRAHEVSEIS VRTVYPPEEE TGERVQLAHH FSEPEHHHHH H

Q&A

What is the genomic organization of the GYPA gene?

The GYPA gene is located on the long arm of chromosome 4 (4q31) and consists of 7 exons. It shares significant sequence homology with related glycophorin genes, particularly GYPB and GYPE, with approximately 97% sequence identity from the 5' untranslated transcription region to the coding sequence encoding the first 45 amino acids . This high homology reflects their evolutionary relationship through gene duplication events. The transmembrane domain is encoded at the point where sequence divergence begins, with an Alu repeat found within the intron downstream of this region . This genomic architecture contributes to the gene's susceptibility to recombination events that generate blood group variants.

How has the glycophorin gene family evolved?

The glycophorin gene family evolved through two separate gene duplication events. The initial duplication created two ancestral genes, one evolving into GypA and the other subsequently giving rise to GypB and GypE through a second duplication event . These evolutionary events appear to have occurred within a relatively short time span, with the second duplication likely resulting from an unequal crossing over event. Phylogenetic analysis indicates that GypA can be found in all primates, providing evidence of its evolutionary conservation across species . This evolutionary history is critical for understanding the functional divergence among glycophorin proteins and their roles in human biology.

What is GYPA's role in blood group determination?

Glycophorins A and B are major sialoglycoproteins of the human erythrocyte membrane which bear the antigenic determinants for the MN and Ss blood groups respectively . Beyond the common M or N and S or s antigens found in all populations, approximately 40 related variant phenotypes have been identified . These variants include all variants of the Miltenberger complex and several isoforms of Sta, as well as Dantu, Sat, He, Mg, and deletion variants such as Ena, S-s-U- and Mk . The majority of these variant phenotypes result from gene recombination events between GYPA and GYPB. MN allele frequencies and genotypes have been extensively documented, with consistent patterns observed across populations .

What evidence supports natural selection acting on GYPA?

Population genetic analyses have revealed compelling evidence of natural selection acting on GYPA, particularly in populations from malaria-endemic regions. Statistical tests of neutrality, especially Tajima's D, show significantly positive values for exon 2 in samples from sub-Saharan Africans, South Asians, and Europeans (p<0.05), but not East Asians . This pattern indicates an excess of intermediate frequency variants, consistent with balancing selection. When analyzing the Human Genome Diversity Panel-Centre d'Etude du Polymorphisme Humain (HGDP-CEPH) samples from 52 populations, Tajima's D was significantly positive in sub-Saharan Africans (D = 3.29, p<0.01) and Europeans (D = 2.18, p<0.05) . These findings suggest that GYPA has been subject to balancing selection in populations living in malaria-endemic areas and, interestingly, also in Europeans, potentially indicating multiple selective pressures acting on this gene.

How does nucleotide diversity at GYPA compare to other genes?

Despite evidence of balancing selection, which typically increases genetic diversity, nucleotide diversity (π) at GYPA is remarkably low compared to other genes. Analysis of sequencing data reveals that estimates of π were relatively low in sub-Saharan Africans (<5%), Europeans (<5%), and East Asians (<10%) compared to data from the Environmental Genome Project (EGP) . Collectively, nucleotide variation in GYPA was lower than in more than ninety percent of known genes . This seemingly contradictory pattern suggests a complex evolutionary history where balancing selection may be acting on specific regions (particularly exon 2) rather than the entire gene, or where other evolutionary forces have constrained variation across most of the locus.

What methodological approaches are most effective for detecting selection at GYPA?

Given GYPA's location in a region with high recombination rates, standard tests that rely on the allele frequency spectra, such as Tajima's D, may have reduced sensitivity when applied across the entire gene . The research suggests two more effective approaches:

  • Focused analysis of functional regions: Tests concentrated on exon 2, which encodes the extracellular domain interacting with P. falciparum's EBA-175, revealed significant signatures of selection that were not apparent when analyzing the entire gene .

  • Sliding window analysis: Using a window size of 300 bp with an offset of 150 bp, researchers tested 28 windows across 4,038 bp of sequence data, allowing for more precise identification of putative selected regions . This approach demonstrated that Tajima's D values were significantly positive in specific regions in sub-Saharan African and South Asian populations.

These methods highlight the importance of targeted approaches when investigating selection patterns in genes with high recombination rates or region-specific selective pressures.

How does GYPA function as a receptor for Plasmodium falciparum?

GYPA serves as the major receptor to which Plasmodium falciparum, the most virulent malaria parasite affecting humans, binds to invade erythrocytes. Specifically, the 175-kD erythrocyte binding antigen (EBA-175) of P. falciparum recognizes and docks to a receptor binding ligand on Glycophorin A . This interaction is critical for the parasite's invasion process, making GYPA a key player in malaria pathogenesis. Importantly, exon 2 of GYPA, which shows significant signatures of balancing selection, encodes the human extracellular domain that directly interacts with P. falciparum's EBA-175 . This biological relationship provides a plausible explanation for the selective pressures observed at GYPA, particularly in populations from malaria-endemic regions.

Interestingly, while the GPA-dependent pathway represents the primary means by which P. falciparum invades human cells, haematologically normal individuals lacking both GPA and GPB on their erythrocyte surface can still be infected with P. falciparum . This observation indicates the existence of alternative invasion pathways and adds complexity to our understanding of host-parasite interactions in malaria.

What are the population-specific patterns of GYPA variation?

Analysis of GYPA variation across diverse populations reveals distinct patterns that may reflect differential selective pressures. The table below summarizes Tajima's D statistics for GYPA by population:

Population GroupTajima's D (Whole Gene)Tajima's D (Exon 2)Significance (Exon 2)
Sub-Saharan AfricaPositive3.29p<0.01
South AsiaPositivePositivep<0.05
EuropePositive2.18p<0.05
East AsiaNegativeNot significantN.S.

These population-specific patterns suggest that while malaria may be a significant selective force on GYPA in sub-Saharan Africa and South Asia, other selective pressures have potentially shaped GYPA variation in Europeans . The absence of selection signatures in East Asian populations further supports the hypothesis that selection on GYPA varies geographically and may be influenced by multiple environmental factors.

What sequencing approaches are recommended for GYPA analysis?

For comprehensive analysis of GYPA variation, researchers should consider sequencing each exon and approximately 1 kb upstream and downstream of each exon . This approach allows for identification of both coding and regulatory variants that may affect GYPA expression or function. In the studies analyzed, this methodology identified 37 variable sites across four populations, including five insertion/deletion (indel) polymorphisms and 32 single nucleotide variants (SNVs) . The majority of these variants were intronic, with five non-synonymous SNVs (four in exon 2) and one synonymous SNV in exon 2 . Additionally, two SNVs were identified in the 5′ UTR and one in the 3′ UTR.

For population-level studies, targeted sequencing of exon 2 may be sufficient to capture the most functionally relevant and selectively constrained variation, as demonstrated by the significant selection signatures observed specifically in this region .

How should researchers account for recombination in GYPA analysis?

GYPA is located in a genomic region with high recombination rates, which can complicate population genetic analyses . To account for this, researchers should:

  • Use methods that are robust to recombination, such as sliding window analyses that can detect localized signatures of selection .

  • Focus on specific functional regions (e.g., exon 2) rather than the entire gene when testing for selection .

  • Consider the role of gene conversion and unequal crossing over in generating variant phenotypes, particularly when studying blood group variants .

  • Use simulations that incorporate realistic recombination rates when generating null distributions for statistical tests of neutrality .

These approaches help mitigate the potentially confounding effects of recombination and increase the power to detect true signals of selection at GYPA.

Product Science Overview

Introduction

Glycophorin A (GPA) is a significant sialoglycoprotein found in the membrane of human erythrocytes (red blood cells). It plays a crucial role in maintaining the structural integrity and functionality of red blood cells. The recombinant form of Glycophorin A is produced using advanced biotechnological methods, allowing for its use in various research and clinical applications.

Structure and Composition

Glycophorin A is a transmembrane protein composed of 131 amino acids. The recombinant human Glycophorin A protein typically includes a sequence from Met1 to Glu91, expressed with a C-terminal polyhistidine tag for purification purposes . The recombinant protein is produced in HEK293 cells, ensuring proper post-translational modifications such as glycosylation, which is essential for its biological activity .

Molecular Characteristics

The recombinant human Glycophorin A comprises 83 amino acids and has a predicted molecular mass of 9.4 kDa. However, due to glycosylation, the apparent molecular mass of the protein is approximately 35-45 kDa and 20 kDa in SDS-PAGE under reducing conditions . This glycosylation is crucial for the protein’s stability and function.

Biological Functions

Glycophorin A is involved in various biological processes, including:

  • Cell-Cell Interactions: It mediates interactions between red blood cells and other cells, playing a role in cell adhesion.
  • Pathogen Binding: GPA serves as a receptor for certain pathogens, including the malaria parasite Plasmodium falciparum, facilitating their entry into red blood cells.
  • Blood Group Antigen: It carries the MN blood group antigens, which are important for blood transfusion compatibility.
Applications

Recombinant Glycophorin A is used in several research and clinical applications:

  • Immunoassays: It is used as a standard or control in various immunoassays to study red blood cell antigens.
  • Vaccine Development: GPA is explored as a target for vaccine development against malaria and other infectious diseases.
  • Drug Discovery: It is used in drug screening assays to identify compounds that can inhibit pathogen binding to red blood cells.
Production and Purification

The production of recombinant Glycophorin A involves the expression of the GPA gene in HEK293 cells. The protein is then purified using affinity chromatography, leveraging the polyhistidine tag for efficient purification . The final product is lyophilized from sterile PBS, pH 7.4, and typically contains protectants such as trehalose, mannitol, and Tween80 to ensure stability during storage .

Stability and Storage

Recombinant Glycophorin A is stable for up to twelve months when stored at -20°C to -80°C under sterile conditions. It is recommended to aliquot the protein to avoid repeated freeze-thaw cycles, which can degrade the protein .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.